Paul Rivard, EVP of Operations, GC at MyMD Pharmaceuticals, Inc. (MYMD), bought 10,000 shares at $1.53 ($15K) on 2022-12-08, disclosed to the SEC on 2022-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| MYMD | BUY | 2021-11-24 | $90K | — | Filing → |